Related references
Note: Only part of the references are listed.Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience
Ralf Bieker et al.
BLOOD (2009)
αvβ3/αvβ5 Integrins-FAK-RhoB: A Novel Pathway for Hypoxia Regulation in Glioblastoma
Nicolas Skuli et al.
CANCER RESEARCH (2009)
Systemic siRNA delivery to leukocyte-implicated diseases
Dan Peer et al.
CELL CYCLE (2009)
siRNA Delivery with Integrin LFA-1-targeted Nanoparticles Prevents HIV Infection in Humanized Mice
Sang-Soo Kim et al.
CLINICAL IMMUNOLOGY (2009)
Inflammation, Microenvironment, and the Immune System in Cancer Progression
Andrew Keibel et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Targeted delivery of thrombolytic agents: role of integrin receptors
Suresh P. Vyas et al.
EXPERT OPINION ON DRUG DELIVERY (2009)
RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer
Hui Zhao et al.
JOURNAL OF DRUG TARGETING (2009)
RGD-IL-24, A Novel Tumor-Targeted Fusion Cytokine: Expression, Purification and Functional Evaluation
Bin Xiao et al.
MOLECULAR BIOTECHNOLOGY (2009)
Inhibition of vimentin or β1 integrin revert morphology of prostate tumor cells grown in laminin-rich extracellular matrix gels and reduces tumor growth in vivo
Xueping Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Single Subcutaneous Administration of RGDK-Lipopeptide:rhPDGF-B Gene Complex Heals Wounds in Streptozotocin-Induced Diabetic Rats
Jayanta Bhattacharyya et al.
MOLECULAR PHARMACEUTICS (2009)
Design of a Multifunctional PLGA Nanoparticulate Drug Delivery System: Evaluation of its Physicochemical Properties and Anticancer Activity to Malignant Cancer Cells
Zhe Wang et al.
PHARMACEUTICAL RESEARCH (2009)
Selectins Ligand Decorated Drug Carriers for Activated Endothelial Cell Targeting
Xavier Banquy et al.
BIOCONJUGATE CHEMISTRY (2008)
Cellular Delivery and Biological Activity of Antisense Oligonucleotides Conjugated to a Targeted Protein Carrier
Hyunmin Kang et al.
BIOCONJUGATE CHEMISTRY (2008)
Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy
Jong-Ho Kim et al.
BIOMATERIALS (2008)
Pharmacology of the novel antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2): Observation of a U-shaped dose-response curve in several preclinical models of angiogenesis and tumor growth
Fernando Donate et al.
CLINICAL CANCER RESEARCH (2008)
Integrin αvβ3-Targeted Cancer Therapy
Zhaofei Liu et al.
DRUG DEVELOPMENT RESEARCH (2008)
Evaluation of biodistribution and anti-tumor effect of a dimeric RGD peptide-paclitaxel conjugate in mice with breast cancer
Qizhen Cao et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric brain tumor consortium study PBTC-012
Tobey J. MacDonald et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Lipopeptide with a RGDK Tetrapeptide Sequence Can Selectively Target Genes to Proangiogenic α5β1 Integrin Receptor and Mouse Tumor Vasculature
Dipankar Pramanik et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Anti-integrin monoclonal antibody CNTO 95 enhances the therapeutic efficacy of fractionated radiation therapy in vivo
Shoucheng Ning et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
Eric A. Murphy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target
Dan Peer et al.
SCIENCE (2008)
CNTO 95, a fully human anti αv integrin antibody, inhibits cell signaling, migration, invasion, and spontaneous metastasis of human breast cancer cells
Qiming Chen et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
RGD peptide grafted biodegradable amphiphilic triblock copolymer poly(glutamic acid)-b-poly(L-lactide)-b-poly(glutamic acid):: Synthesis and self-assembly
Chao Deng et al.
JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY (2007)
A phase I trial of sorafenib (BAY 43-9006) for patients with recurrent or progressive malignant glioma (NABTT 0401)
L. B. Nabors et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma
L. Burt Nabors et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Electrostatic ligand coatings of nanoparticles enable ligand-specific gene delivery to human primary cells
Jordan J. Green et al.
NANO LETTERS (2007)
Phase I evaluation of a fully human anti-αv integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumors
Saifee A. Mullamitha et al.
CLINICAL CANCER RESEARCH (2007)
Synthesis and characterization of RGD-fatty acid amphiphilic micelles as targeted delivery carriers for anticancer agents
Steve I. Shen et al.
JOURNAL OF DRUG TARGETING (2007)
Recent advancement of understanding pathogenesis of type 1 diabetes and potential relevance to diabetic nephropathy
Kunihiro Ichinose et al.
AMERICAN JOURNAL OF NEPHROLOGY (2007)
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer
Helmut Friess et al.
BMC CANCER (2006)
Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems
Norased Nasongkla et al.
NANO LETTERS (2006)
Synthesis of poly(β-amino ester)s with thiol-reactive side chains for DNA delivery
Gregory T. Zugates et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo
Parisa Khalili et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Phase II evaluations of cilengitide in asymptomatic patients with androgen-independent prostate cancer: Scientific rationale and study design
Kathleen W. Beekman et al.
CLINICAL GENITOURINARY CANCER (2006)
Integrins in drug targeting-RGD templates in toxins
X. Lu et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Cell adhesion molecules for targeted drug delivery
Alison L. Dunehoo et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Enhancement of adenovirus-mediated gene delivery to rheumatoid arthritis synoviocytes and synovium by fiber modifications: Role of arginine-glycine-aspartic acid (RGD)and non-RGD-binding integrins
ML Toh et al.
JOURNAL OF IMMUNOLOGY (2005)
Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic
XB Xiong et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Soluble Flt-1 gene delivery using PEI-g-PEG-RGD conjugate for anti-angiogenesis
WJ Kim et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy:: In vitro and in vivo
XB Xiong et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Targeting of the antivascular drug combretastatin to irradiated tumors results in tumor growth delay
CB Pattillo et al.
PHARMACEUTICAL RESEARCH (2005)
Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery
XY Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells
P Hölig et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2004)
Coupling tumor necrosis factor-α with αv integrin ligands improves its antineoplastic activity
F Curnis et al.
CANCER RESEARCH (2004)
CNTO 95, a fully human monoclonal antibody that inhibits αv integrins, has antitumor and antiangiogenic activity in vivo
M Trikha et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle
RM Schiffelers et al.
NUCLEIC ACIDS RESEARCH (2004)
cRGD-functionalized polymer micelles for targeted doxorubicin delivery
N Nasongkla et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2004)
Addition of integrin binding sequence to a mutant human endostatin improves inhibition of tumor growth
Y Yokoyama et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Crucial role for interferon γ in the synergism between tumor vasculature-targeted tumor necrosis factor α (NGR-TNF) and doxorubicin
A Sacchi et al.
CANCER RESEARCH (2004)
Liposomes modified with cyclic RGD peptide for tumor targeting
PK Dubey et al.
JOURNAL OF DRUG TARGETING (2004)
Docking studies on αvβ3 integrin ligands:: Pharmacophore refinement and implications for drug design
L Marinelli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Therapeutic antagonists and conformational regulation of integrin function
M Shimaoka et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression
G Christofori
EMBO JOURNAL (2003)
Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins αvβ3 and αvβ5 in patients with advanced solid tumours
FALM Eskens et al.
EUROPEAN JOURNAL OF CANCER (2003)
Inhibition of integrin α5β1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice
O Stoeltzing et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
The combinatorial synthesis of bicyclic privileged structures or privileged substructures
DA Horton et al.
CHEMICAL REVIEWS (2003)
Use of RNA interference to inhibit integrin (alpha 6 beta 4)-mediated invasion and migration of breast carcinoma cells
EA Lipscomb et al.
CLINICAL & EXPERIMENTAL METASTASIS (2003)
Targeting of Lipid-Protamine-DNA (LPD) lipopolyplexes using RGD motifs
P Harvie et al.
JOURNAL OF LIPOSOME RESEARCH (2003)
A new gene structure of the disintegrin family: A subunit of dimeric disintegrin has a short coding region
D Okuda et al.
BIOCHEMISTRY (2002)
Integrins: Bidirectional, allosteric signaling machines
RO Hynes
CELL (2002)
Tumor regression by targeted gene delivery to the neovasculature
JD Hood et al.
SCIENCE (2002)
Role of integrins in cell invasion and migration
JD Hood et al.
NATURE REVIEWS CANCER (2002)
Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery
BJ Lestini et al.
JOURNAL OF CONTROLLED RELEASE (2002)
Synergistic inhibitory activity of α- and β-LFA-1 peptides on LFA-1/ICAM-1 interaction
H Yusuf-Makagiansar et al.
PEPTIDES (2001)
A pilot trial of vitaxin, a humanized anti-vitronectin receptor (anti αvβ3) antibody in patients with metastatic cancer
JA Posey et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2001)
Binding and internalization of an LFA-1-derived cyclic peptide by ICAM receptors on activated lymphocyte: A potential ligand for drug targeting to ICAM-1-expressing cells
H Yusuf-Makagiansar et al.
PHARMACEUTICAL RESEARCH (2001)
Focal adhesions: A nexus for intracellular signaling and cytoskeletal dynamics
SK Sastry et al.
EXPERIMENTAL CELL RESEARCH (2000)
Share Paper
